Justice Dept. Unveils Medicare Fraud Charges as Part of Larger Health Care Prosecutions

The Department of Justice launched a major fraud prosecution targeting unnecessary use of expensive skin substitutes in wound care treatment. These products, designed to help heal severe burns and chronic wounds, cost Medicare nearly $15 billion in 2025 alone.

Skin substitutes represent a particularly costly area of health care fraud because the products themselves are legitimate medical treatments. The problem lies in how they're prescribed. Providers bill Medicare for these expensive wound care products in cases where standard, far cheaper treatments would work just as well.

The overuse appears systemic. Medicare data shows skin substitutes get applied to wounds that traditionally heal fine with basic wound dressings, antibiotics, and proper care. The Justice Department's investigation uncovered patterns where providers ordered these products routinely, regardless of clinical necessity.

This prosecution fits into a broader Department of Justice effort to combat health care fraud across the system. Rather than targeting obvious schemes, federal prosecutors increasingly focus on treatments that exist within standard medical practice but get overused or misprescribed.

The financial stakes matter enormously for Medicare's sustainability. At $15 billion annually for a single product category, even modest reductions in unnecessary use could free substantial resources for other beneficiaries. The department's action signals that regulators now view prescribing patterns, not just fraudulent billing, as prosecution targets.

For patients, the implications extend beyond costs. Unnecessary medical interventions carry their own risks. Some skin substitutes require specific wound conditions to work effectively. Using them inappropriately can delay appropriate treatment or create complications.

The prosecution represents a shift in how federal authorities approach health care fraud. Rather than waiting for whistleblowers or obvious billing errors, prosecutors now examine prescribing data to identify potential overuse. This approach requires collaboration between Department of Justice officials and Medicare's data analysts.

Patients receiving wound care should ask their providers whether skin substitutes are truly necessary or whether standard dressings